The discovery that drug-resistant tumor cells express high levels of UCP2 [14,42], which has been linked to protection against oxidative stress, pointed to UCP2 as a new drug target for cancer treatment [13,15,16,17,24,42]. The gene discussed is UCP2; the disease is neoplasm.